AIC
ADPT icon

Archer Investment Corporation’s Adaptive Biotechnologies ADPT Stock Holding History

Archer Investment Corporation’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,000
Closed -$6K – 1137
2024
Q4 		$6K Hold
1,000
– – ﹤0.01% 799
2024
Q3 		$5.12K Hold
1,000
– – ﹤0.01% 801
2024
Q2 		$3.62K Buy
+1,000
New +$3.17K ﹤0.01% 823

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Archer Investment Corporation's ADPT Position: Q1 2025 in Review

Archer Investment Corporation sold out of Adaptive Biotechnologies (ADPT) in Q1 2025, closing a stake of 1,000 shares — an estimated $6K sold.

Archer Investment Corporation first reported a position in ADPT in Q2 2024 and held it in 3 quarters. The position peaked at $6K in Q4 2024. 225 funds tracked by Wall St. Rank hold ADPT as of Q1 2025.

  • Archer Investment Corporation reported no remaining Adaptive Biotechnologies position as of Q1 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 1,000 Adaptive Biotechnologies shares in Q1 2025, an estimated $6K.
  • Archer Investment Corporation first reported a position in Adaptive Biotechnologies in Q2 2024 and held it in 3 quarters.
  • Archer Investment Corporation's Adaptive Biotechnologies position peaked at $6K in Q4 2024.
  • 225 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2025.

Based on Archer Investment Corporation's 13F filing for Q1 2025, filed 5 May 2025.